3 ms·
They are marketing the device strictly to make referrals to specialists. The FDA press release says as much anyway: https://www.fda.gov/NewsEvents/Newsroom/Pre
by maxerickson 9y ago
They are marketing the device strictly to make referrals to specialists. The FDA press release says as much anyway:
https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm604357.htm https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/u...
If the images are of sufficient quality, the software provides the doctor with one of two results: (1) “more than mild diabetic retinopathy detected: refer to an eye care professional” or (2) “negative for more than mild diabetic retinopathy; rescreen in 12 months.” If a positive result is detected, patients should see an eye care provider for further diagnostic evaluation and possible treatment as soon as possible.
Are you interpreting the Verge or talking about some other statement?
- asperous 9y agoYeah from the article: > IDx-DR founder Michael Abràmoff told Science News. “It makes the clinical decision on its own.” But I would guess a specialist would still need to be involved since it's not a fool-proof system. A specialist might take other symptoms or variables into account when making the diagnosis or order further tests. While this tool might be useful for blanket screening considering that it is harmless, it seems like it's hardly going to be "making the decision on its own" and prescribing treatment.
- maxerickson 9y agoIt's specifically making the clinical decision I quote from the FDA press release, whether or not to refer to a specialist for further diagnosis. It's not something primary care doctors currently do.